Ontology highlight
ABSTRACT: Introduction
While breast cancer outcomes are improving steadily in younger women due to advances in screening and improved therapies, there has been little change in outcomes among the older age group. It is inevitable that comorbidities/frailty rates are higher, which may increase the risks of some breast cancer treatments such as surgery and chemotherapy, many older women are healthy and may benefit from their use. Adjusting treatment regimens appropriately for age/comorbidity/frailty is variable and largely non-evidence based, specifically with regard to rates of surgery for operable oestrogen receptor-positive disease and rates of chemotherapy for high-risk disease.Methods and analysis
This multicentre, parallel group, pragmatic cluster randomised controlled trial (RCT
SUBMITTER: Collins K
PROVIDER: S-EPMC5642653 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature